KALOS with EFA® -Technology
The Cough Assist KALOS with EFA® technology (Expiratory Flow Accelerator) from the manufacturer Medical Product Research (MPR) helps patients whose ability to cough effectively is severely limited. These patients are unable to cough up secretions on their own due to diseases of the respiratory system.
The Cough Assist function initially generates an overpressure in the patient’s respiratory system that can be adjusted on the device, and then switches to a negative pressure that is also adjustable and independent of the overpressure in a very short time, which enables the secretions to be mobilized and coughed up more easily and effectively.
The innovative, globally unique and patented EFA® technology offers a particularly gentle therapy for ineffective coughing by accelerating the exhalation flow. EFA® promotes deep drainage and secretion removal without exerting additional pressure on the airways. This means that EFA® is not only a valuable therapy supplement but can also be used as an alternative for patients who do not accept Cough Assist therapy.
Overall, KALOS is characterized by its simple and intuitive application, with all functions shown on a color display and selected and adjusted using just one control button. The low weight, small dimensions and internal rechargeable battery offer medical professionals, nursing staff and, last but not least, patients a high degree of flexibility.
In addition to KALOS, Medical Product Research (MPR) offers a wide variety of other innovative respiratory therapy devices.
For further information, please use the contact form on this website.
___________________________________________________________________________________________________________